# Acadia Healthcare Company, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Acadia Healthcare Company, Inc.). ## Overview Acadia Healthcare Company, Inc. operates behavioral healthcare facilities focused on patients with high-acuity and complex mental health and substance use needs. Its network includes inpatient psychiatric hospitals, residential treatment centers, outpatient programs, and opioid treatment clinics, with growth driven by facility expansions, joint ventures, de novo openings, and acquisitions. As of year-end 2025, the company operated 277 facilities with more than 12,500 beds across 40 states and Puerto Rico. The business is built around referral relationships, payer reimbursement, and the ability to add capacity in attractive markets while integrating acquired facilities and improving operating performance. ## Products & services • Inpatient psychiatric care • Substance abuse treatment • Outpatient psychiatric care • Adolescent residential treatment • Opioid treatment centers (CTCs) • Joint venture behavioral health facilities • Facility expansions and bed additions - **Inpatient behavioral healthcare** (55%) — Acute psychiatric and substance use treatment delivered in hospital-style settings for complex patients. - **Outpatient and community-based care** (15%) — Psychiatric outpatient services and related programs that treat patients without overnight stays. - **Residential treatment** (10%) — Adolescent and other residential programs for patients needing structured, longer-duration care. - **Opioid treatment centers** (10%) — CTCs that provide medication-assisted treatment and related services for opioid use disorder. - **Joint venture and de novo growth facilities** (10%) — Newly opened or partnered facilities that expand capacity and broaden the care continuum. - Inpatient psychiatric care - Substance abuse treatment - Outpatient psychiatric care - Adolescent residential treatment - Opioid treatment centers (CTCs) - Joint venture behavioral health facilities - Facility expansions and bed additions ## Customers Acadia serves patients referred for behavioral health and substance use treatment, especially those with high-acuity or complex needs that require structured clinical settings. Its customers are not only individual patients but also the referral sources and payers that direct and reimburse care, including healthcare practitioners, emergency departments, managed care organizations, public programs, judicial officials, social workers, police departments, and families. A large share of revenue is tied to Medicaid, Medicare, commercial insurers, and other government programs, so payer mix and state reimbursement rules are central to demand and economics. The company also relies on hospitals and local providers that refer patients who need specialized behavioral health services rather than general medical care. - **High-acuity behavioral health patients** (primary) — Patients requiring inpatient psychiatric, residential, or intensive treatment for complex mental health and substance use conditions. - **Referral sources** (primary) — Hospitals, physicians, emergency departments, courts, social workers, and other intermediaries that direct patients into Acadia's facilities. - **Government payers** (primary) — State Medicaid programs, Medicare, and other public programs that reimburse a large portion of services. - **Commercial insurers and managed care** (secondary) — Private payers that cover behavioral health services and influence pricing, utilization, and access. - **Out-of-state and regional referral patients** (secondary) — Patients traveling across state lines to access specialized facilities, especially in larger multi-state markets. - Patients needing inpatient psychiatric or substance use treatment - Patients referred from hospitals, emergency departments, and physicians - Medicaid and other state program beneficiaries - Commercially insured behavioral health patients - Medicare and other federal program patients - Families, courts, and social services seeking structured care ## Geography Acadia's operations are concentrated in the United States, with facilities in 40 states and Puerto Rico at year-end 2025. Management highlighted Pennsylvania, Tennessee, and California as especially important markets, together representing about 31% of total revenue, which makes the company sensitive to state-level reimbursement, regulatory, and competitive changes. The company also noted that some facilities serve patients from neighboring states and receive Medicaid payments from those states, so cross-border coverage rules can affect utilization. Geography matters because behavioral health demand is local, but referral patterns, payer rules, and state Medicaid policies can materially change facility economics. - **Pennsylvania** (13%) — Disclosed as a major state market in 2025 revenue concentration. - **Tennessee** (10%) — Disclosed as a major state market in 2025 revenue concentration. - **California** (8%) — Disclosed as a major state market in 2025 revenue concentration. - **Other U.S. states and Puerto Rico** (69%) — Residual share after the three named states. - Operations span 40 states and Puerto Rico - Pennsylvania, Tennessee, and California are the largest disclosed states - Several facilities draw patients from neighboring states - State Medicaid policy can affect reimbursement and access - Local competition and staffing conditions vary by market - Facility expansion targets attractive regional behavioral health markets ## Strategy Acadia's strategy is to build a national behavioral health platform for high-acuity patients by expanding capacity and broadening its continuum of care. Management is pursuing five growth pathways: expanding existing facilities, forming joint ventures, opening de novo facilities, acquiring facilities, and adding services across the care continuum. The company is also trying to improve operating performance through better management systems, stronger referral relationships, and selective investment in markets where it can scale. Joint ventures with health systems and targeted acquisitions are important because they provide access to new markets and help add beds without relying solely on greenfield development. - **Add beds through expansions and new facilities** (short-term) — Capacity growth is the main way to capture demand in a fragmented market and increase patient throughput. - **Deepen joint venture partnerships** (medium-term) — Partnerships with health systems improve market access, referral flow, and speed to scale. - **Broaden the continuum of care** (medium-term) — Offering more service types increases referral capture and helps retain patients across treatment settings. - **Improve facility-level operating performance** (short-term) — Better staffing, management systems, and turnaround of underperforming sites support margins and quality. - Expand existing facilities to add beds in established markets - Use joint ventures with health systems to accelerate market entry - Open de novo facilities in attractive behavioral health markets - Acquire facilities to deepen geographic scale and service breadth - Grow referral networks and out-of-state patient volume - Improve underperforming facilities through management and operating discipline ## Risks Acadia faces regulatory and reimbursement risk because a large share of revenue comes from Medicaid, Medicare, and other government programs, and state policy changes can quickly affect facility economics. The company is also exposed to staffing shortages, turnover, and wage inflation because behavioral health care depends on psychiatrists, nurses, counselors, and other licensed personnel. Competitive pressure is significant, with hospitals, nonprofit providers, local operators, and other for-profit chains competing for patients, referral sources, and acquisitions. Operational risks include cybersecurity, information system failures, quality-of-care issues, lease renewals, and impairment risk at underperforming facilities, while concentration in Pennsylvania, Tennessee, and California increases sensitivity to local policy changes. - **State reimbursement and Medicaid policy changes** [high] — A meaningful portion of revenue comes from state programs, and the company disclosed concentration in Pennsylvania, Tennessee, and California. - **Labor shortages and clinician retention** [high] — Behavioral health facilities require psychiatrists, nurses, counselors, and support staff; shortages can limit admissions and raise costs. - **Competitive pressure for patients and referrals** [medium] — Hospitals, nonprofit providers, and other behavioral health operators compete for the same patient flow and contracts. - **Cybersecurity and information system failure** [high] — The company relies on clinical and billing systems, and a breach or outage could disrupt care and trigger penalties. - **Goodwill and asset impairment** [high] — The company recorded large impairment charges in 2025, showing sensitivity to revised forecasts and underperforming facilities. - Medicaid and state reimbursement changes can reduce revenue and margins - Labor shortages and turnover can raise wage costs and limit capacity - Competition for patients and referral sources can pressure volumes - Quality-of-care failures could damage reputation and referral relationships - Cybersecurity or IT outages could disrupt operations and create liability - State concentration increases exposure to local regulatory and policy shifts - Acquisition and integration risk can dilute returns if facilities underperform ## Accounting Revenue is recognized for services rendered to patients, but reported amounts depend heavily on estimated contractual adjustments, discounts for uninsured patients, and implicit price concessions. Because reimbursement comes from Medicaid, Medicare, commercial insurers, and patients, collections can differ from billed charges and require judgment in estimating the transaction price and accounts receivable. The company also has meaningful seasonality and quarter-to-quarter variability tied to patient volumes, staffing, and facility openings, which can make same-facility comparisons and new-facility ramp-up effects important for analysis. A major accounting issue is impairment testing: Acadia recorded $1.0079 billion of non-cash impairment charges in 2025, including $996.2 million of goodwill impairment, so investors should watch how changes in forecasts, discount rates, and facility performance affect future earnings and book value. - **Revenue recognition and accounts receivable estimates** — Revenue and working capital - **Goodwill and long-lived asset impairment** — Earnings and balance sheet carrying values - **Same-facility versus total results** — Operating trend interpretation - **Lease accounting and facility closures** — Operating expenses and asset impairments - Revenue estimates depend on contractual adjustments and collection assumptions - Accounts receivable valuation reflects expected payer mix and collectability - Same-facility results help separate organic performance from new openings and closures - Quarterly results can swing with patient volumes, staffing, and facility ramp-up - Goodwill and long-lived asset impairment can create large non-cash charges - Lease and facility closure accounting can affect operating expenses and asset values --- *Last updated: 2026-08-11T04:46:19.348429+00:00*